~~<i id='681AB196F4'><strike id='681AB196F4'><tt id='681AB196F4'><pre id='681AB196F4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：focus 2025-09-29 01:07:05 - browse：45522

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： It was time to plan for my old age. If only I could stop crying

entertainment

focus

explore

leisure time

hotspot

ArielBrigham,whowasunabletoaccessdialysisduringHurricaneHarveyin2017,posesforaportraitinherhome.Mich

WSS

Twill hunts for pharma partner to market its depression app

With heat waves through August, officials warn of health risks

Trump used to be more articulate. What could explain the change?

US soldier in North Korean custody after crossing DMZ line

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Restaurant meals are packed with calories, and we still keep eating them

Wikipedia

hotspot

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

Feed a cold, starve a fever? Here’s what science says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Trump demands the U.S. pay no more for drugs than other countries … again

Flash flood warnings continue for parts of Missouri, Illinois

DIEP, the 'gold standard' of breast reconstruction, is under threat

Failure, not just success, should guide future doctors

Bright Health sells Medicare Advantage business to Molina

FDA seeking to stop procedures at two unregulated stem cell clinics

entertainment

St. Louis police protesters begin picking up checks in $4.9 million settlement

Paxlovid rebound happens. Why and to whom are still a mystery

How CRISPR works, explained in two minutes

Paxlovid rebound happens. Why and to whom are still a mystery

US soldier in North Korean custody after crossing DMZ line

Google's generative AI to analyze medical images — and talk to docs

focus

explore

leisure time

hotspot